Literature DB >> 22927475

Surgical technique and peripheral artery disease.

David Paul Slovut1, Evan C Lipsitz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22927475     DOI: 10.1161/CIRCULATIONAHA.111.059048

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  19 in total

1.  Prospects for multimodality imaging in peripheral artery disease.

Authors:  Scott Kinlay
Journal:  Circ Cardiovasc Imaging       Date:  2014-01       Impact factor: 7.792

2.  Minimal clinically important differences in treadmill, 6-minute walk, and patient-based outcomes following supervised and home-based exercise in peripheral artery disease.

Authors:  Andrew W Gardner; Polly S Montgomery; Ming Wang
Journal:  Vasc Med       Date:  2018-04-19       Impact factor: 3.239

3.  Management of Critical Limb Ischemia.

Authors:  Scott Kinlay
Journal:  Circ Cardiovasc Interv       Date:  2016-02       Impact factor: 6.546

4.  Axillobifemoral bypass: a brief surgical and historical review.

Authors:  Priti L Mishall; Jason D Matakas; Keara English; Katherine Allyn; Diane Algava; Ruth A Howe; Sherry A Downie
Journal:  Einstein J Biol Med       Date:  2016

5.  Potential of Autologous Progenitor Cells and Decellularized Porcine Artery Matrix in Construction of Tissue-engineered Vascular Grafts.

Authors:  Jieh-Neng Wang; Chung-Dann Kan; Shao-Hsien Lin; Ko-Chi Chang; Stephanie Tsao; Tak-Wah Wong
Journal:  Organogenesis       Date:  2021-08-18       Impact factor: 2.316

6.  Elevated serum phosphate levels are associated with decreased amputation-free survival after interventions for critical limb ischemia.

Authors:  Sara L Zettervall; Peter A Soden; Klaas H J Ultee; Crystal Seldon; Jinhee Oh; Kevin McGann; Marc L Schermerhorn; Raul J Guzman
Journal:  J Vasc Surg       Date:  2016-09-22       Impact factor: 4.268

7.  Accelerated Blood Clearance Phenomenon Reduces the Passive Targeting of PEGylated Nanoparticles in Peripheral Arterial Disease.

Authors:  Hyung-Jun Im; Christopher G England; Liangzhu Feng; Stephen A Graves; Reinier Hernandez; Robert J Nickles; Zhuang Liu; Dong Soo Lee; Steve Y Cho; Weibo Cai
Journal:  ACS Appl Mater Interfaces       Date:  2016-07-07       Impact factor: 9.229

8.  Re-assessing the enhanced permeability and retention effect in peripheral arterial disease using radiolabeled long circulating nanoparticles.

Authors:  Christopher G England; Hyung-Jun Im; Liangzhu Feng; Feng Chen; Stephen A Graves; Reinier Hernandez; Hakan Orbay; Cheng Xu; Steve Y Cho; Robert J Nickles; Zhuang Liu; Dong Soo Lee; Weibo Cai
Journal:  Biomaterials       Date:  2016-05-21       Impact factor: 12.479

Review 9.  Antithrombotic Therapy After Peripheral Vascular Intervention.

Authors:  Peter Hu; Schuyler Jones
Journal:  Curr Cardiol Rep       Date:  2016-03       Impact factor: 2.931

10.  Tissue engineered bovine saphenous vein extracellular matrix scaffolds produced via antigen removal achieve high in vivo patency rates.

Authors:  Manuela Lopera Higuita; Juan F Lopera Giraldo; Tiffany L Sarrafian; Leigh G Griffiths
Journal:  Acta Biomater       Date:  2021-06-27       Impact factor: 10.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.